Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,660.00
+60.00 (1.07%)
At close: Aug 7, 2025, 3:30 PM KST
1.07%
Market Cap85.41B
Revenue (ttm)106.99B
Net Income (ttm)5.52B
Shares Out15.17M
EPS (ttm)364.11
PE Ratio15.46
Forward PEn/a
Dividend60.00 (1.06%)
Ex-Dividend DateDec 27, 2024
Volume32,987
Average Volume99,204
Open5,600.00
Previous Close5,600.00
Day's Range5,590.00 - 5,680.00
52-Week Range4,700.00 - 8,730.00
Beta0.36
RSI43.58
Earnings DateAug 13, 2025

About MorphoSys AG

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The co... [Read more]

Industry Pharmaceutical Preparations
Founded 1959
Employees 351
Stock Exchange KOSDAQ
Ticker Symbol 002800
Full Company Profile

Financial Performance

In 2024, Sinsin Pharmaceutical's revenue was 106.39 billion, an increase of 3.71% compared to the previous year's 102.59 billion. Earnings were 4.89 billion, an increase of 4.46%.

Financial Statements

News

There is no news available yet.